Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called ReachDeck to read and / or translate its content. To use ReachDeck, you must allow ReachDeck cookies; the ReachDeck icon will then appear at the bottom right of your screen.
You can find out more about how ReachDeck uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow ReachDeck cookies Do not use ReachDeck
Please find service updates and current visiting rules in our COVID-19 section.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
Detection of the BCR-ABL fusion gene - screen for the presence of BCR-ABL fusion transcripts using multiplex PCR.
BCR-ABL quantification - quantification of BCR-ABL transcript level and monitoring of minimal residual disease.
BCR-ABL T315I analysis - pyrosequencing for this variant only. M91.11 and M91.12 can be undertaken as sendaway tests. Please contact us to discuss.
As outlined in the Test Directory.
There are several of the rarer FISH investigations outlined in the Test Directory that we do not provide (e.g. M91.25, M91.27 & M91.29 as well as many others).
Please contact us to discuss forwarding the sample elsewhere for FISH investigations.
If there are tumour and germline samples available, along with appropriate consent, these will be forwarded to the WMRGL for further processing.